This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a bromo and fluoro substituent, makes it a valuable intermediate in the design of molecules targeting central nervous system disorders. Researchers often explore its potential in creating compounds with enhanced binding affinity to specific receptors, which could lead to the development of new therapies for conditions such as depression, anxiety, or neurodegenerative diseases. Additionally, its unique tetrahydrocyclopenta[b]indole core is of interest in medicinal chemistry for optimizing pharmacokinetic properties and improving drug efficacy.